Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A. Cyclosporin G (CsG) is an analogue of cyclosporin A (CsA) with strong immunosuppressive activity. We compared these two drugs in a rat model in which salt depletion promotes irreversible renal interstitial fibrosis with renal dysfunction in animals given CsA for three weeks. When both drugs were given in the same dosage on a weight basis (15 mg/kg/day, subcutaneously), CsA blood levels were higher than CsG (3305 vs. 1824 ng/ml, P < 0.001).
In this study we compared the toxicity and pharmacokinetics of CsA and CsG in an experimental model of chronic cyclosporine-induced nephropathy. In this model, rats given CsA on a salt-depleted diet develop severe decreases in glomerular filtration rate as well as irreversible striped tubulointerstitial injury similar to the histological lesion found in human chronic CsA-induced nephrotoxicity [21, 22] . Methods 
Animals
Adult male Sprague-Dawley rats (Charles River, Wilmington, Massachusetts, USA) weighing 250 g were housed in individual cages in a temperature-and light-controlled environment. They received a salt-free boiled rice diet (8.5% of protein, 76.6% of carbohydrate, less than 4.3% of fat, enriched with ferric orthophosphate and thiamine mononitrate) and were allowed free access to tap water.
Drugs
CsA and CsG (Sandoz Research Institute, East Hanover, New Jersey, USA) were dissolved in anhydrous ethanol (12. 5%) and mixed with olive oil (87.5%) to a final concentration of 7.5 mg/mi and 15 mg/mi of CsA, and 15 mg/ml and 25 mg/mI of CsG.
Basic protocol
The rats received one intraperitoneal injection of furosemide (4 mg/kg) and started the rice diet. After one week weightmatched pairs of rats were randomly assigned to receive a daily subcutaneous injection of CsA 15 mg/kg (CsA15, N = 20), CsG 15 mg/kg (CsG15, N = 21) or an identical volume of vehicle (VH, N = 27). In order to obtain similar blood levels of CsA and CsG, an additional group of rats were randomized to receive CsA 7.5 mg/kg (CsA7.5, N = 15) or CsG 25 mg/kg (CsG25, N = 13) . Body weight was measured daily throughout the experiment. After three weeks of treatment on rice diet the rats had the tail blood pressure (BP) measured with a plethysmograph (Narco Bio-systems, Houston, Texas, USA) and were placed in metabolic cages (Nalge Company, Rochester, New York, USA) for urine collection. After 24 hours, a blood sample was drawn and, as previously designated for each rat, the glomerular filtration rate (GFR) was measured by '4C-inulin clearance or the left kidney was collected for histology after in situ perfusion.
Inulin clearance After anesthesia polyethylene tubes (PE-50) were placed in the jugular vein for blood collection and in the femoral vein for infusion. A polyethylene tube (PE-90) was also placed and sutured in the bladder. A loading dose of 0.25 Ci '4C-inulin in 6 ml 1% NaHCO3 was given followed by a maintenance infusion of 2.5 Ci 14C-inulin in 10 ml 1% NaHCO3 at a rate of 52 1.dlmin.
After a 30-minute equilibration time, urine was collected over four periods of at least 20 minutes each in preweighed vials. A blood sample (0.35 ml) was drawn at the midpoint of each urine collection and replaced with an equal volume of 1% NaHCO3.
Inulin clearances values expressed as ml/min/l00 g body wt represent the mean of the four clearance periods. After the end of the inulin clearance the rat was euthanized, the left kidney was removed and weighed.
In situ perfusion After anesthesia the rat received 500 U of heparin i.v. and a ventral midline incision was made exposing the abdominal aorta, posterior vena cava, left and right renal vessels. The aorta and vena cava just above the bifurcation to the legs plus the mesenteric and right kidney arteries were tied. A ligature was loosely tied around the aorta and vena cava above the renal arteries. An 18-gauge needle was introduced in the abdominal aorta pointing towards the kidneys. An infusion of 10 ml of saline was started at the same time as the ligature above the renal arteries was tied and a hole was made in the left renal vein. After the saline flush, six minutes of perfusion with 1% glutaraldehyde in a modified 3/4 Tyrode buffer was done. The pressure in the system was kept stable at 140 to 160 mm Hg and the flow at 10 to 12 mI/mm. After the perfusion the left kidney was removed, weighed and placed in a vial with the perfusion solution.
Renal histology
The renal tissue was processed, embedded in plastic and cut at I p. as in previous studies [21, 22] . The extent of tubulointerstitial injury (fibrosis and tubular atrophy) was evaluated semi-quantitatively (0 to 4+) in a blinded way (Dr. S. Rosen).
Approximately six sections (3 x 3 mm) were analyzed per animal. These sections included both horizontal and the traditional sagittal sections. Interstitial fibrosis and tubular atrophy in the cortex was first seen predominantly in the medullary ray. These first recognizable changes were graded as trace. As the injury involved the medullary ray more extensively, the changes were considered 1+. When the medullary ray changes were widespread, a 2+ grade was given. With increasing degrees of fibrosis, the labyrinth was involved and depending on the extent, the grades were 3 or 4+. In the medulla, the first changes related to tubular atrophy were often associated with casts. Initially, these alterations were unaccompanied by fibrotic change. Occasional atrophic tubules were graded trace. As the changes became more extensive, a grade 1+ was given. When the process became somewhat diffuse, a 2+ score was given. At this time, a fibrotic component began to be seen.
Higher scores depended on further increases in atrophic change and the degree of accompanying fibrosis.
Liver histology
Liver specimens were fixed in 10% neutral buffered formalin and processed and embedded in paraffin using standard techniques. Histologic sections, 5 p. in thickness, were cut from the paraffin block and stained with hematoxylin and eosin, Mallory's trichrome, and periodic acid-Schiff's stain following diastase digestion. The sections were examined and morphologic features assessed without knowledge of the experimental manipulation (Dr. Randall G. Lee).
Pharmacokinetic study
CsA and CsG solutions were prepared diluting the drug with ethanol (12.5%) and intralipid (87.5%) (KabiVitrum, Clayton, North Carolina, USA) to a final concentration of 15 mglml. Rats weighing 300 g were kept for seven days on rice diet and in the eighth day polyethylene tubes (PE-50) were placed in both jugular veins and CsA (N = 6) or CsG (N = 7)15 mg/kg was given by the left jugular vein over an average time of one minute. Blood samples were drawn from the right jugular vein at 2, 5, 15, 30, 60, 120, 180, 360 and 1440 minutes after the infusion of the drug. Animals were kept under light anesthesia throughout the procedure. CsA and CsG concentration versus time data were analyzed using noncompartmental analysis. The elimination rate constant (kel) was determined as the terminal slope of the linear least-squares regression line of a semilogarithmic plot of concentration versus time data. Area under the concentration versus time curve (AUC) was calculated by the linear trapezoidal rule and extrapolated to infinity (AUC0OO). The terminal area was determined by dividing the last measured concentration by the terminal slope (kel). Noncompartmental analysis was used to calculate total body clearance (CL) and apparent volume of distribution (Varea) according to the following equations:
Half-life (t112) was calculated by the equation t112 = 0.693/kel.
Tissue concentrations of cyclosporine
Rats kept on rice diet were given CsA (N = 5) or CsG (N = 4) s.c. as already described. After three weeks of treatment the animals were euthanized and kidney and liver samples were collected. The tissue was weighed and homogenized with 3 ml of methanol (50°C) in a glass jar with Teflon. Tissue homogenized was centrifuged at 3000 x g during 10 minutes (room temperature) and the supernatant was saved. Then, 3 ml of methanol was added again to the tissue and the procedure repeated. The total obtained supematant was dried under nitrogen and saved at -20°C to further analysis. Kidney and liver samples from a rat given only the vehicle were used as control. (27) 0.42 0.01 (24) 27.7 2.3 (27) 116.9 3.7 (22) CsA 15 mg 0.86 0.14 (20) 0.41 0.01 (20) 22.5 2.5 (20) 116.6 3.8 (15) CsG 15mg 1.33 0.13 (21) 0.43 0.01 (21) 20.9 1.6 (20) 118.9 3.4 (16) Data are presented as mean sEM; Number of rats are in parentheses. Abbreviations are: iBody wt, variation in body weight; Kidney wt, kidney weight; UV, urinary volume; BP, blood pressure; VH, vehicle. a P < 0.05 vs. VH Analytical methods Urinary and serum sodium and potassium were measured by flame photometer (Instrumentation Laboratories, Lexington, Massachusetts, USA). Urinary and serum creatinine, urinary and serum magnesium, serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), serum total bilirubin (TB) and urinary N-acetyl /3-D-glucosaminidase (NAG) were measured by a Cobas autoanalyzer (Roche Diagnostics, Hoffman-La Roche Division, Nutley, New Jersey, USA). Urinary enzymes results were normalized by the urinary creatinine concentration. Cyclosporine whole-blood levels and tissue levels were determined by a specific CsA monoclonal radioimmunoassay (Incstar Corp., Stillwater, Minnesota, USA). CsA antibody has been shown to have equal affinity for CsA and CsG and monoclonal radioimmunoassay have given results comparable to HPLC [1, 23] . Serum and urine radioactivity were measured by a Beckman LS 100 liquid scintillation counter (Beckman Instruments, Palo Alto, California, USA). The clearance of inulin (GFR), clearance of creatinine (Car), fractional excretion of sodium (FENa), fractional excretion of potassium (FEK) and fractional excretion of magnesium (FEM5) were calculated by the standard formulas.
Statistical analysis
Results are presented as mean SEM. Comparisons between CsA and CsG in the pharmacokinetic and cyclosporine tissue concentration analysis were done by two-tailed unpaired Student's f-test or Mann-Whitney test, as appropriate. Multiple comparisons were done by ANOVA followed by Tukey-Kramer test or by Kruskal-Wallis test followed by Dunn's test, as appropriate. The level of statistical significance was chosen as P < 0.05.
Results
Rats given CsA gained less body weight than those receiving only vehicle (P < 0.05), while the daily variation in body weight was similar between CsG and vehicle animals. There were no differences in kidney weight, blood pressure or urinary volume among the three groups (Table 1) .
Twenty-four-hour trough cyclosporine blood levels
When CsA and CsG were given in the same dosage on a weight basis the CsA blood level was almost two times higher than the CsG blood level (P < 0.001, CsA1S vs. CsG15). The increase of CsG daily dosage to 25 mg/kg resulted in cyclosporifle blood level similar to that found with CsG 15 and therefore still lower than CsA1S (P < 0.001). We only achieved comparable blood level between CsA and CsG when the CsA daily dosage was decreased to 7.5 mg/kg, which resulted in a cyclosporine blood level similar to that found for CsG 15 and significantly lower than the CsA1S value (P < 0.001; Fig. 1 ).
Renal function
Rats given CsA had a lower GFR (P < 0.01, CsA7.5 vs. VH and P < 0.001, CsA15 vs. VH), lower Cr (P < 0.001, CsA7.5 vs. VH and CsA15 vs. VH) and higher serum creatinine (P < 0.05, CsA7.5 vs. VH and P < 0.001, CsAl5 vs. VH) as compared to control animals. There were no significant differences in renal function between CsG and control rats. However, when CsA and CsG rats were compared CsA-treated animals showed a lower GFR (P < 0.05, CsAl5 vs. CsG15 and P < 0.01, CsA15 vs. CsG2S), lower Cci (P < 0.05, CsA7.5 VS. CsGL5 and CsA15 vs. CsG2S and P < 0.01, CsA1S vs. CsGl5) and higher serum creatinine (P < 0.001, CsAl5 vs. CsG15) than CsG rats ( Table 2) .
The urinary excretion of N-acetyl f3-D-glucosaminidase was significantly higher in CsA animals as compared to vehicle (P < 0.01, CsA7.5 vs. VH and P < 0.001, CsA1S vs. VH) or CsG rats (P < 0.05, CsA7.5 vs. CsG15 and P < 0.01, CsA15 vs. CsGL5; Table 2 ).
Serum sodium and FENa were similar among groups. The FENa was virtually zero reflecting the severe dietary sodium restriction. Although serum potassium was higher in CsG group (P < 0.05 vs. VH), FEK was elevated in CsA-treated rats (P < 0.05 vs. VH). Both CsA and CsG rats showed decreased serum magnesium as compared to control animals (P < 0.001, CsA15 vs. VH and P < 0.05, CsG15 vs. VH) and FEMg higher than that found for vehicle-treated animals. Nevertheless, the differences in FEMg were not statistically significant (Table 3 ).
Renal histology
The most striking histological changes in cyclosporinetreated animals were interstitial fibrosis and tubular atrophy. The injury was most pronounced in the medullary ray, giving the characteristic striped appearance and in the inner stripe of 
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CsA-treated rats had a higher cortical injury score than vehicle (P < 0.001, CsA7.5 vs. VH and CsA15 vs. VH) or CsG-treated rats (P < 0.001, CsA7.5 vs. CsG15, CsA15 vs. CsGl5, CsA7.5 vs. CsG25 and CsA15 vs. CsG2S). CsA animals also showed a higher medullary injury score than vehicle (P < 0.001, CsA7.5 vs. VH and CsA15 vs. VH) or CsG animals (P < 0.001, CsA7.5 vs. CsG15;P <0.01, CsA15 vs. CsG15; andP <0.001, CsA7.5 vs. CsG25). Although the interstitial fibrosis score of CsG-treated rats was higher than that found in control animals the difference did not achieve statistical significance (Table 2, Fig. 2) .
Liver function and histology
The values of AST and ALT of either CsA or CsG animals were not increased as compared to animals receiving vehicle. Both CsA and CsG rats presented increased TB as compared to control animals. Nevertheless, this difference was not statistically significant (Table 4) .
Liver histology was consistently normal or showed mild fatty changes, without differences between cyclosporine-or vehicletreated animals ( Table 4 ).
Pharmacokineric study
CsG had a higher clearance than CsA resulting in lower trough blood levels. There was also smaller area under the curve, higher volume of distribution and lower renal and hepatic levels of CsG. While CsA treated rats had similar renal and hepatic tissue cyclosporine levels, CsG-treated animals had cyclosporine liver tissue levels two times higher as compared to the renal tissue levels ( Table 5 , Fig. 3 ).
Discussion
The price for the widespread and prolonged use of CsA, even with therapeutic drug monitoring, is its chronic nephrotoxicity. The therapeutic window, if one truly exists, is narrow and some degree of renal dysfunction is the general rule when glomerular filtration rate is the renal parameter measured [24] . Several approaches have been tried to bypass these problems, including a search for safer yet effective cyclosporine analogues. In 1985, Hienstand and colleagues reported that cyclosporin G (CsG) or Nva-2 cyclosporine had similar immunosuppression activity but less nephrotoxicity than CsA in rats [2] . The enthusiasm about CsG was tempered by the conflicting results following the initial report. Comparison among the different studies is difficult since animal species, strain, dosage, route of administration and duration of treatment were not uniform. Most authors have In rats treated with CsG only slight interstitial fibrosis and tubular atrophy are seen related to a medullary ray (center). When CsA is given, the interstitial fibrosis and tubular atrophy are much more extensive. x75, x75. used only serum creatinine or creatinine clearance to measure renal function. Trough cyclosporine blood levels of CsA and CsG have not always been measured and when they were different no attempt was made to obtain comparable blood concentrations. Finally, it is not known if CsG induces chronic tubulointerstitial damage to the same extent as CsA. In this study we took advantage of an experimental model of cyclosporineinduced chronic nephrotoxicity in salt-depleted rats to compare CsA and CsG using both similar doses on a weight basis and similar trough blood levels of the two drugs.
While CsA produced a major decrease in GFR and creatinine clearance and increased serum creatinine, CsG-treated rats had renal function similar to control animals. These results are consistent with previous studies which also found increased serum creatinine in CsA but not CsG-treated rats after three or more weeks of treatment [12, 15, 16] . Duncan et a!, using Sprague-Dawley rats, found a slight but significant increase in serum creatinine and decrease in Ce,, with both CsG and CsA. However, these changes were more marked in CsA rats and CsG-treated rats had Ccr significantly higher than CsA animals [3] . Only two other studies have measured GFR by inulin clearance to assess renal function in comparative studies. One found decreased GFR and renal plasma flow (RPF) in CsA but not CsG rats after three weeks of cyclosponne treatment and in the other the acute intravenous infusion of either CsA or CsG in rats promoted similar falls in GFR and RPF [13, 14] . An elegant study by Rooth et a! demonstrated that CsA infusion in mice induced an almost complete inhibition of subcapsular blood flow. CsG only decreased blood flow at high infusion rates, but the inhibition was still significantly below that produced by CsA [25] . in vitro studies showed that CsG was less toxic than CsA to LLC-PK cells [26] . Preliminary results of clinical trials in (7) 42 5 (7) 0.67 0.07 (7) CsAl5mg 11O±9 (7) 27±2 (7) 0.97±0.11 (6) CsGl5mg 1l3±9a (6) 28±2 (6) 0.96±0.09 (5) Data are mean SEM; Number of rats are in parentheses. Abbreviations are: AST, aspartate aminotransferase; ALT, alanine aminotransferase; TB, total bilirubin. a p < 0.05 vs. VH renal transplantation have also suggested less nephrotoxicity for CsG than CsA as measured by serum creatinine and inulin clearance [9-111. Probably more important than the preservation of GFR was the finding of considerably less cortical and medullary histological injury in CsG rats as compared to CsA. Other experimental studies in rats and rabbits also found less interstitial fibrosis with CsG [1, 8] . There are no clinical data available yet for comparison. Progressive renal failure and chronic striped interstitial fibrosis have been described in solid organ transplantation and in patients with autoimmune diseases receiving CsA [27] [28] [29] . The renal dysfunction occurs even with low cyclosporine dosage and may be progressive despite drug dose reduction [30] [31] [32] . The experimental model used in the present study reproduces the pattern of striped interstitial fibrosis described in patients receiving CsA. Elzinga, Rosen and Bennett showed in this model that the tubulointerstitial injury progressed despite withdrawal of CsA [22] . If our experimental findings are confirmed by the ongoing clinical trials, CsG may become an important alternative for long-term transplant and nontransplant immunosuppression.
CsA induced significant NAG enzymuria and a high FEK in presence of very low FENa and levels of serum potassium similar to that found im placebo rats, suggesting a distal tubule lesion [33, 34] . In contrast CsG-treated rats had urinary excretion of NAG and FEK similar to control animals. Both cyclosponnes induced hypomagnesemia and an inappropriately high fractional excretion of magnesium, supporting the concept that the decrease in serum magnesium is not related with the changes in GFR [35] . Since CsG has shown immunosuppressive activity equivalent to CsA at dosages lower than those used in this study, the occurrence of less nephrotoxicity with CsG suggests that the mechanisms of cyclosporine toxicity and immunosuppression may be independent. However, we did not do a direct comparison between CsA and CsG immunosuppressive efficacy, and it remains possible that decreased renal toxicity and decreased immunosuppressive activities co-exist at these doses. Presently it is not clear why CsG is less nephrotoxic. One possible explanation might be related to differences in drug metabolism, but CsG metabolites have structures consistent with those identified for CsA [36] . Both drugs bound to cyclophilin equally [37] . Although the pharmacokinetics of the two drugs was clearly different, CsG was still less nephrotoxic when equiva- Hepatotoxicity disclosed by increased serum bilirubin and elevation in liver enzymes has been reported in experimental animals receiving CsA or CsG [3, 13, 18, 28] . Results from clinical trials are controversial. Huser et al reported increased bilirubin, increased liver enzymes and abnormal liver histology in three CsG-treated patients that improved after discontinuation of the drug [19] . However, in larger series of CsG-treated patients only slight elevations in liver enzymes were observed [9] [10] [11] . Both drugs were toxic in vitro to human hepatoblastoma * * * * * cells [40] . In the present study there was a clear trend to increased serum bilirubin with either CsA or CsG, but liver enzymes and liver histology were normal. It is not clear why the liver enzymes in CsA and CsG-treated animals were below the values found for control rats.
Conflicting results have also been reported comparing the pharmacokinetics of CsG and CsA. The variations are likely related to differences in animal species and strain. In rats, similar [3, 8, 16] , lower [12, 41] , and higher [7, 15] trough CsG blood levels as compared to CsA were observed. Pharmacokinetic studies in rabbits were consistent with the results found in our study, showing faster elimination and lower blood levels for CsG [1, 42] . In this study, even increasing the dose of CsG from 15 to 25 mg/kg we did not observe an increased blood level of the drug. In dogs CsG blood levels are higher and CsG clearance lower as compared to CsA [43] . In humans, the first published study suggested similar pharmacokinetics for CsA and CsG [44], but subsequent studies showed that at equivalent doses cyclosporine blood levels were higher with CsG [9] [10] [11] 19 ].
In summary, CsG induced less tubulointerstitial injury and less glomerular and tubular dysfunction than CsA when the two drugs were given in equivalent dosages by weight or when similar trough blood levels of both drugs were achieved. These findings are only partially explained due to differences in pharmacokinetics and suggest innate differences in tissue uptake and nephrotoxic potential of the two drugs. Other mediators of cyclosporine nephrotoxicity must be studied in experimental animals as well as in humans given CsG in order to clarify the mechanisms and implications of these results.
